Key result
Catheter ablation emerges as primary treatment for idiopathic VT and reduces VT burden in SHD.
Why the study?
Does catheter ablation improve outcomes and reduce arrhythmia burden in patients with ventricular tachycardia?
Population
Patients with ventricular tachycardia, including idiopathic VT and VT associated with structural heart disease
Design
Review
Authors
Loading...
Supports ablation strategies for idiopathic VT; leaves open need for randomized outcome trials in structural disease.
Does catheter ablation improve outcomes and reduce arrhythmia burden in patients with ventricular tachycardia?
Catheter ablation is a key therapeutic strategy for managing idiopathic ventricular tachycardia and reducing VT burden in patients with structural heart disease.
Tanawuttiwat et al. (2015) conducted a review in Ventricular tachycardia. Catheter ablation was evaluated. Catheter ablation has emerged as the primary treatment for idiopathic ventricular tachycardia and an important strategy to reduce VT burden in patients with structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: